A Boston Hedge Fund Just Made $950 Million On One Stock Today
Reuters/ Brian Snyder
Adage Capital is located on the 52nd floor of the John Hancock Tower
The stock surged about 283%, or about $167, since the opening bell.
At least one hedge fund is probably really pleased with this investment.
The largest shareholder of Puma Biotechnology is Adage Capital Management, a Boston-based hedge fund founded by Phil Gross and Robert Atchinson.
According to the latest 13F data, Adage last held 5,686,668 shares. That means they have made about $950 million on the position since the opening bell today.
Adage first reported its position in Puma Biotechnology on December 31, 2012. The fund held about 5.2 million shares then. From that time until yesterday's market close, shares of Puma Biotechnology have risen 214%.
And all those who sold out of the position before this news broke are probably kicking themselves right about now.
Next Story
Saudi Arabia wants China to help fund its struggling $500 billion Neom megaproject. Investors may not be too excited.
I spent $2,000 for 7 nights in a 179-square-foot room on one of the world's largest cruise ships. Take a look inside my cabin.
One of the world's only 5-star airlines seems to be considering asking business-class passengers to bring their own cutlery
RBI bars Kotak Mahindra Bank from onboarding new customers via online, issuing fresh credit cards
GIGABYTE AORUS CO49DQ 49-inch QD-OLED 144Hz curved gaming monitor launched in India
Sensex, Nifty climb on firm trend in global markets
Things to do in Goa in monsoon to make the most out of your trip
Healthy choices for summer: 7 soups to support your weight loss goals
